The global Human Rabies Vaccine market is projected to reach US$ 1422.9 million by 2030 from an estimated US$ 1105.3 million in 2024, at a CAGR of 4.3% during 2024 and 2030.

Human Rabies Vaccine Market

Rabies Vaccine is an immunization drug used to prevent rabies in people who have been bitten by an animal or otherwise exposed to the rabies virus.

There are a number of rabies vaccines available that are both safe and effective. They can be used to prevent rabies, before or after exposure to the rabies virus, which is commonly caused by a dog bite or a bat bite.

Global Human Rabies Vaccine market leaders include Chengda Bio, Bharat Biotech, Bavarian Nordic, Sanofi-Pasteur, etc. All of the above hold over 65 percent market share.

Asia-Pacific is the largest consumption area, with a consumption market share close to 60%. Besides, North Americas is the second largest consumption area with a consumption market share of over 15%.

The classification of Human Rabies Vaccine includes Vero Cell, BHK, Chick Embryo Cell, Human Diploid Cells, and Others. In addition, the proportion of Vero Cell rabies vaccines is about 85%.

Human Rabies Vaccine is widely used for Pre-exposure and Post-exposure. The segment of Human Rabies Vaccine used for Post-exposure and the market share is over 70% of the share.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Human Rabies Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyse their position in the current marketplace, and make informed business decisions regarding Human Rabies Vaccine.

The Human Rabies Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Human Rabies Vaccine market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Human Rabies Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application, and regions.

Market Segmentation

Scope of Human Rabies Vaccine Market Report

Report Metric	Details
Report Name	Human Rabies Vaccine Market
Accounted market size in 2024	an estimated US$ 1105.3 million
Forecasted market size in 2030	US$ 1422.9 million
CAGR	4.3%
Base Year	2024
Forecasted years	2024 - 2030
Segment by Type	Vero Cell BHK Chick Embryo Cell Human Diploid Cells Others
Segment by Application	Pre-Exposure Vaccine Post-Exposure Vaccine
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Bharat Biotech, Bavarian Nordic, Sanofi-Pasteur, Chengda Bio, KANGH, Prcmise, Henan Grand Biopharma, Zhuoyi Biological, ZhongKe Biopharm, Ningbo Rongan Biological, Indian Immunologicals
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Human Rabies Vaccine in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 3: Detailed analysis of Human Rabies Vaccine manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Human Rabies Vaccine sales, revenue, price, gross margin, sales by region, by Type, by Application, and recent development, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: APAC by Type, by Application and by country, sales, and revenue for each segment.
Chapter 9: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 10: Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Middle East and Africa by Type, by Application and by country, sales, and revenue for each segment.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: Research Findings and Conclusion.

FAQ for this report

How fast is Human Rabies Vaccine Market growing?

Ans: The Human Rabies Vaccine Market witnessing a CAGR of 4.3% during the forecast period 2024-2030.

What is the Human Rabies Vaccine Market size in 2030?

Ans: The Human Rabies Vaccine Market size in 2030 will be US$ 1422.9 million.

What is the Human Rabies Vaccine Market share by region?

Ans: Asia-Pacific is the largest consumption area, with a consumption market share close to 60%. Besides, North Americas is the second largest consumption area with a consumption market share of over 15%.

What is the Human Rabies Vaccine Market share by type?

Ans: In addition, the proportion of Vero Cell rabies vaccines is about 85%.

Who are the main players in the Human Rabies Vaccine Market report?

Ans: The main players in the Human Rabies Vaccine Market are Bharat Biotech, Bavarian Nordic, Sanofi-Pasteur, Chengda Bio, KANGH, Prcmise, Henan Grand Biopharma, Zhuoyi Biological, ZhongKe Biopharm, Ningbo Rongan Biological, Indian Immunologicals

What are the Application segmentation covered in the Human Rabies Vaccine Market report?

Ans: The Applications covered in the Human Rabies Vaccine Market report are Pre-Exposure Vaccine, Post-Exposure Vaccine

What are the Type segmentation covered in the Human Rabies Vaccine Market report?

Ans: The Types covered in the Human Rabies Vaccine Market report are Vero Cell, BHK, Chick Embryo Cell, Human Diploid Cells, Others

1 Study Coverage

1.1 Human Rabies Vaccine Product Introduction

1.2 Market by Type

1.2.1 Global Human Rabies Vaccine Market Size Growth Rate by Type (2019 VS 2023 VS 2030)

1.2.2 Vero Cell

1.2.3 BHK

1.2.4 Chick Embryo Cell

1.2.5 Human Diploid Cells

1.2.6 Others

1.3 Market by Application

1.3.1 Global Human Rabies Vaccine Market Size Growth Rate by Application (2019 VS 2023 VS 2030)

1.3.2 Pre-Exposure Vaccine

1.3.3 Post-Exposure Vaccine

1.4 Study Objectives

1.5 Years Considered

2 Executive Summary

2.1 Global Human Rabies Vaccine Market Size Estimates and Forecasts

2.1.1 Global Human Rabies Vaccine Revenue 2019-2030

2.1.2 Global Human Rabies Vaccine Sales 2019-2030

2.2 Human Rabies Vaccine Market Size by Region: 2023 Versus 2030

2.3 Human Rabies Vaccine Sales by Region (2019-2030)

2.3.1 Global Human Rabies Vaccine Sales by Region: 2019-2024

2.3.2 Global Human Rabies Vaccine Sales Forecast by Region (2025-2030)

2.3.3 Global Human Rabies Vaccine Sales Market Share by Region (2019-2030)

2.4 Human Rabies Vaccine Market Estimates and Projections by Region (2025-2030)

2.4.1 Global Human Rabies Vaccine Revenue by Region: 2019-2024

2.4.2 Global Human Rabies Vaccine Revenue Forecast by Region (2025-2030)

2.4.3 Global Human Rabies Vaccine Revenue Market Share by Region (2019-2030)

3 Global Human Rabies Vaccine by Manufacturers

3.1 Global Top Human Rabies Vaccine Manufacturers by Sales

3.1.1 Global Human Rabies Vaccine Sales by Manufacturer (2019-2024)

3.1.2 Global Human Rabies Vaccine Sales Market Share by Manufacturer (2019-2024)

3.2 Global Top Human Rabies Vaccine Manufacturers by Revenue

3.2.1 Global Human Rabies Vaccine Revenue by Manufacturer (2019-2024)

3.2.2 Global Human Rabies Vaccine Revenue Share by Manufacturer (2019-2024)

3.3 Global Human Rabies Vaccine Price by Manufacturer (2019-2024)

3.4 Competitive Landscape

3.4.1 Key Human Rabies Vaccine Manufacturers Covered: Ranking by Revenue

3.4.2 Global Human Rabies Vaccine Market Concentration Ratio (CR5 and HHI) & (2019-2024)

3.4.3 Global Human Rabies Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

3.5 Global Human Rabies Vaccine Manufacturing Base Distribution, Product Type

3.5.1 Human Rabies Vaccine Manufacturers Manufacturing Base Distribution, Headquarters

3.5.2 Manufacturers Human Rabies Vaccine Product Type

3.5.3 Date of International Manufacturers Enter into Human Rabies Vaccine Market

3.6 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Company Profiles

4.1 Bharat Biotech

4.1.1 Bharat Biotech Company Information

4.1.2 Bharat Biotech Description, Business Overview

4.1.3 Bharat Biotech Human Rabies Vaccine Products Offered

4.1.4 Bharat Biotech Human Rabies Vaccine Sales, Revenue and Gross Margin (2019-2024)

4.1.5 Bharat Biotech Human Rabies Vaccine Sales by Product in 2023

4.1.6 Bharat Biotech Human Rabies Vaccine Sales by Application in 2023

4.1.7 Bharat Biotech Human Rabies Vaccine Sales by Geographic Area in 2023

4.1.8 Bharat Biotech Recent Developments

4.2 Bavarian Nordic

4.2.1 Bavarian Nordic Company Information

4.2.2 Bavarian Nordic Description, Business Overview

4.2.3 Bavarian Nordic Human Rabies Vaccine Products Offered

4.2.4 Bavarian Nordic Human Rabies Vaccine Sales, Revenue and Gross Margin (2019-2024)

4.2.5 Bavarian Nordic Human Rabies Vaccine Sales by Product in 2023

4.2.6 Bavarian Nordic Human Rabies Vaccine Sales by Application in 2023

4.2.7 Bavarian Nordic Human Rabies Vaccine Sales by Geographic Area in 2023

4.2.8 Bavarian Nordic Recent Developments

4.3 Sanofi-Pasteur

4.3.1 Sanofi-Pasteur Company Information

4.3.2 Sanofi-Pasteur Description, Business Overview

4.3.3 Sanofi-Pasteur Human Rabies Vaccine Products Offered

4.3.4 Sanofi-Pasteur Human Rabies Vaccine Sales, Revenue and Gross Margin (2019-2024)

4.3.5 Sanofi-Pasteur Human Rabies Vaccine Sales by Product in 2023

4.3.6 Sanofi-Pasteur Human Rabies Vaccine Sales by Application in 2023

4.3.7 Sanofi-Pasteur Human Rabies Vaccine Sales by Geographic Area in 2023

4.3.8 Sanofi-Pasteur Recent Developments

4.4 Chengda Bio

4.4.1 Chengda Bio Company Information

4.4.2 Chengda Bio Description, Business Overview

4.4.3 Chengda Bio Human Rabies Vaccine Products Offered

4.4.4 Chengda Bio Human Rabies Vaccine Sales, Revenue and Gross Margin (2019-2024)

4.4.5 Chengda Bio Human Rabies Vaccine Sales by Product in 2023

4.4.6 Chengda Bio Human Rabies Vaccine Sales by Application in 2023

4.4.7 Chengda Bio Human Rabies Vaccine Sales by Geographic Area in 2023

4.4.8 Chengda Bio Recent Developments

4.5 KANGH

4.5.1 KANGH Company Information

4.5.2 KANGH Description, Business Overview

4.5.3 KANGH Human Rabies Vaccine Products Offered

4.5.4 KANGH Human Rabies Vaccine Sales, Revenue and Gross Margin (2019-2024)

4.5.5 KANGH Human Rabies Vaccine Sales by Product in 2023

4.5.6 KANGH Human Rabies Vaccine Sales by Application in 2023

4.5.7 KANGH Human Rabies Vaccine Sales by Geographic Area in 2023

4.5.8 KANGH Recent Developments

4.6 Prcmise

4.6.1 Prcmise Company Information

4.6.2 Prcmise Description, Business Overview

4.6.3 Prcmise Human Rabies Vaccine Products Offered

4.6.4 Prcmise Human Rabies Vaccine Sales, Revenue and Gross Margin (2019-2024)

4.6.5 Prcmise Human Rabies Vaccine Sales by Product in 2023

4.6.6 Prcmise Human Rabies Vaccine Sales by Application in 2023

4.6.7 Prcmise Human Rabies Vaccine Sales by Geographic Area in 2023

4.6.8 Prcmise Recent Development

4.7 Henan Grand Biopharma

4.7.1 Henan Grand Biopharma Company Information

4.7.2 Henan Grand Biopharma Description, Business Overview

4.7.3 Henan Grand Biopharma Human Rabies Vaccine Products Offered

4.7.4 Henan Grand Biopharma Human Rabies Vaccine Sales, Revenue and Gross Margin (2019-2024)

4.7.5 Henan Grand Biopharma Human Rabies Vaccine Sales by Product in 2023

4.7.6 Henan Grand Biopharma Human Rabies Vaccine Sales by Application in 2023

4.7.7 Henan Grand Biopharma Human Rabies Vaccine Sales by Geographic Area in 2023

4.7.8 Henan Grand Biopharma Recent Development

4.8 Zhuoyi Biological

4.8.1 Zhuoyi Biological Company Information

4.8.2 Zhuoyi Biological Description, Business Overview

4.8.3 Zhuoyi Biological Human Rabies Vaccine Products Offered

4.8.4 Zhuoyi Biological Human Rabies Vaccine Sales, Revenue and Gross Margin (2019-2024)

4.8.5 Zhuoyi Biological Human Rabies Vaccine Sales by Product in 2023

4.8.6 Zhuoyi Biological Human Rabies Vaccine Sales by Application in 2023

4.8.7 Zhuoyi Biological Human Rabies Vaccine Sales by Geographic Area in 2023

4.8.8 Zhuoyi Biological Recent Development

4.9 ZhongKe Biopharm

4.9.1 ZhongKe Biopharm Company Information

4.9.2 ZhongKe Biopharm Description, Business Overview

4.9.3 ZhongKe Biopharm Human Rabies Vaccine Products Offered

4.9.4 ZhongKe Biopharm Human Rabies Vaccine Sales, Revenue and Gross Margin (2019-2024)

4.9.5 ZhongKe Biopharm Human Rabies Vaccine Sales by Product in 2023

4.9.6 ZhongKe Biopharm Human Rabies Vaccine Sales by Application in 2023

4.9.7 ZhongKe Biopharm Human Rabies Vaccine Sales by Geographic Area in 2023

4.9.8 ZhongKe Biopharm Recent Development

4.10 Ningbo Rongan Biological

4.10.1 Ningbo Rongan Biological Company Information

4.10.2 Ningbo Rongan Biological Description, Business Overview

4.10.3 Ningbo Rongan Biological Human Rabies Vaccine Products Offered

4.10.4 Ningbo Rongan Biological Human Rabies Vaccine Sales, Revenue and Gross Margin (2019-2024)

4.10.5 Ningbo Rongan Biological Human Rabies Vaccine Sales by Product in 2023

4.10.6 Ningbo Rongan Biological Human Rabies Vaccine Sales by Application in 2023

4.10.7 Ningbo Rongan Biological Human Rabies Vaccine Sales by Geographic Area in 2023

4.10.8 Ningbo Rongan Biological Recent Development

4.11 Indian Immunologicals

4.11.1 Indian Immunologicals Company Information

4.11.2 Indian Immunologicals Description, Business Overview

4.11.3 Indian Immunologicals Human Rabies Vaccine Products Offered

4.11.4 Indian Immunologicals Human Rabies Vaccine Sales, Revenue and Gross Margin (2019-2024)

4.11.5 Indian Immunologicals Human Rabies Vaccine Sales by Product in 2023

4.11.6 Indian Immunologicals Human Rabies Vaccine Sales by Application in 2023

4.11.7 Indian Immunologicals Human Rabies Vaccine Sales by Geographic Area in 2023

4.11.8 Indian Immunologicals Recent Development

5 Breakdown Data by Type

5.1 Global Human Rabies Vaccine Sales by Type (2019-2030)

5.1.1 Global Human Rabies Vaccine Sales by Type (2019-2024)

5.1.2 Global Human Rabies Vaccine Sales Forecast by Type (2025-2030)

5.1.3 Global Human Rabies Vaccine Sales Market Share by Type (2019-2030)

5.2 Global Human Rabies Vaccine Revenue Forecast by Type (2019-2030)

5.2.1 Global Human Rabies Vaccine Revenue by Type (2019-2024)

5.2.2 Global Human Rabies Vaccine Revenue Forecast by Type (2025-2030)

5.2.3 Global Human Rabies Vaccine Revenue Market Share by Type (2019-2030)

5.3 Human Rabies Vaccine Average Selling Price (ASP) by Type (2019-2030)

6 Breakdown Data by Application

6.1 Global Human Rabies Vaccine Sales by Application (2019-2030)

6.1.1 Global Human Rabies Vaccine Sales by Application (2019-2024)

6.1.2 Global Human Rabies Vaccine Sales Forecast by Application (2025-2030)

6.1.3 Global Human Rabies Vaccine Sales Market Share by Application (2019-2030)

6.2 Global Human Rabies Vaccine Revenue Forecast by Application (2019-2030)

6.2.1 Global Human Rabies Vaccine Revenue by Application (2019-2024)

6.2.2 Global Human Rabies Vaccine Revenue Forecast by Application (2025-2030)

6.2.3 Global Human Rabies Vaccine Revenue Market Share by Application (2019-2030)

6.3 Human Rabies Vaccine Average Selling Price (ASP) by Application (2019-2030)

7 North America

7.1 North America Human Rabies Vaccine Market Size YoY Growth 2019-2030

7.2 North America Human Rabies Vaccine Market Facts & Figures by Country

7.2.1 North America Human Rabies Vaccine Sales by Country (2019-2030)

7.2.2 North America Human Rabies Vaccine Revenue by Country (2019-2030)

7.3 North America Human Rabies Vaccine Sales by Type (2019-2024)

7.4 North America Human Rabies Vaccine Sales by Application (2019-2024)

8 Asia-Pacific

8.1 Asia-Pacific Human Rabies Vaccine Market Size YoY Growth 2019-2030

8.2 Asia-Pacific Human Rabies Vaccine Market Facts & Figures by Region

8.2.1 Asia-Pacific Human Rabies Vaccine Sales by Region (2019-2030)

8.2.2 Asia-Pacific Human Rabies Vaccine Revenue by Region (2019-2030)

8.3 Asia-Pacific Human Rabies Vaccine Sales by Type (2019-2024)

8.4 Asia-Pacific Human Rabies Vaccine Sales by Application (2019-2024)

9 Europe

9.1 Europe Human Rabies Vaccine Market Size YoY Growth 2019-2030

9.2 Europe Human Rabies Vaccine Market Facts & Figures by Country

9.2.1 Europe Human Rabies Vaccine Sales by Country (2019-2030)

9.2.2 Europe Human Rabies Vaccine Revenue by Country (2019-2030)

9.3 Europe Human Rabies Vaccine Sales by Type (2019-2024)

9.4 Europe Human Rabies Vaccine Sales by Application (2019-2024)

10 Latin America

10.1 Latin America Human Rabies Vaccine Market Size YoY Growth 2019-2030

10.2 Latin America Human Rabies Vaccine Market Facts & Figures by Country

10.2.1 Latin America Human Rabies Vaccine Sales by Country (2019-2030)

10.2.2 Latin America Human Rabies Vaccine Revenue by Country (2019-2030)

10.3 Latin America Human Rabies Vaccine Sales by Type (2019-2024)

10.4 Latin America Human Rabies Vaccine Sales by Application (2019-2024)

11 Middle East and Africa

11.1 Middle East and Africa Human Rabies Vaccine Market Size YoY Growth 2019-2030

11.2 Middle East and Africa Human Rabies Vaccine Market Facts & Figures by Country

11.2.1 Middle East and Africa Human Rabies Vaccine Sales by Country (2019-2030)

11.2.2 Middle East and Africa Human Rabies Vaccine Revenue by Country (2019-2030)

11.3 Middle East and Africa Human Rabies Vaccine Sales by Type (2019-2024)

11.4 Middle East and Africa Human Rabies Vaccine Sales by Application (2019-2024)

12 Supply Chain and Sales Channel Analysis

12.1 Human Rabies Vaccine Supply Chain Analysis

12.2 Human Rabies Vaccine Key Raw Materials and Upstream Suppliers

12.3 Human Rabies Vaccine Clients Analysis

12.4 Human Rabies Vaccine Sales Channel and Sales Model Analysis

12.4.1 Human Rabies Vaccine Distribution Channel Analysis: Indirect Sales VS Direct Sales

12.4.2 Human Rabies Vaccine Distribution Channel Analysis: Online Sales VS Offline Sales

12.4.3 Human Rabies Vaccine Distributors

13 Market Dynamics

13.1 Human Rabies Vaccine Industry Trends

13.2 Human Rabies Vaccine Market Drivers

13.3 Human Rabies Vaccine Market Challenges

13.4 Human Rabies Vaccine Market Restraints

14 Research Findings and Conclusion

15 Appendix

15.1 Research Methodology

15.1.1 Methodology/Research Approach

15.1.2 Data Source

15.2 Author Details

15.3 Disclaimer

FEATURED COMPANIES

Henan Grand Biopharma

Zhuoyi Biological

Zhongke Biopharm

Ningbo Rongan Biological

Indian Immunologicals

List of Tables

Table 1. Global Human Rabies Vaccine Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Major Manufacturers of Vero Cell

Table 3. Major Manufacturers of BHK

Table 4. Major Manufacturers of Chick Embryo Cell

Table 5. Major Manufacturers of Human Diploid Cells

Table 6. Major Manufacturers of Others

Table 7. Global Human Rabies Vaccine Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 8. Global Human Rabies Vaccine Market Size by Region (US$ Million): 2023 VS 2030

Table 9. Global Human Rabies Vaccine Sales by Region (2019-2024) & (K Units)

Table 10. Global Human Rabies Vaccine Sales Forecast by Region (2025-2030) & (K Units)

Table 11. Global Human Rabies Vaccine Revenue by Region (2019-2024) & (US$ Million)

Table 12. Global Human Rabies Vaccine Revenue Forecast by Region (2025-2030) & (US$ Million)

Table 13. Global Human Rabies Vaccine Sales by Manufacturer (2019-2024) & (K Units)

Table 14. Global Human Rabies Vaccine Sales Share by Manufacturer (2019-2024)

Table 15. Human Rabies Vaccine Revenue by Manufacturer (2019-2024) & (US$ Million)

Table 16. Human Rabies Vaccine Revenue Share by Manufacturer (2019-2024)

Table 17. Key Manufacturers Human Rabies Vaccine Price (2019-2024) & (US$/Unit)

Table 18. Ranking of Global Top Human Rabies Vaccine Manufacturers by Revenue (US$ Million) in 2023

Table 19. Global Human Rabies Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI) & (2019-2024)

Table 20. Global Human Rabies Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Human Rabies Vaccine as of 2023)

Table 21. Human Rabies Vaccine Manufacturers Manufacturing Base Distribution and Headquarters

Table 22. Manufacturers Human Rabies Vaccine Product Type

Table 23. Date of International Manufacturers Enter into Human Rabies Vaccine Market

Table 24. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 25. Bharat Biotech Company Information

Table 26. Bharat Biotech Description and Business Overview

Table 27. Bharat Biotech Human Rabies Vaccine Product

Table 28. Bharat Biotech Human Rabies Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 29. Bharat Biotech Sales Proportion of Human Rabies Vaccine by Product in 2023

Table 30. Bharat Biotech Sales Proportion of Human Rabies Vaccine by Application in 2023

Table 31. Bharat Biotech Sales Proportion of Human Rabies Vaccine by Geographic Area in 2023

Table 32. Bharat Biotech Recent Development

Table 33. Bavarian Nordic Company Information

Table 34. Bavarian Nordic Description and Business Overview

Table 35. Bavarian Nordic Human Rabies Vaccine Product

Table 36. Bavarian Nordic Human Rabies Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 37. Bavarian Nordic Sales Proportion of Human Rabies Vaccine by Product in 2023

Table 38. Bavarian Nordic Sales Proportion of Human Rabies Vaccine by Application in 2023

Table 39. Bavarian Nordic Sales Proportion of Human Rabies Vaccine by Geographic Area in 2023

Table 40. Bavarian Nordic Recent Development

Table 41. Sanofi-Pasteur Company Information

Table 42. Sanofi-Pasteur Description and Business Overview

Table 43. Sanofi-Pasteur Human Rabies Vaccine Product

Table 44. Sanofi-Pasteur Human Rabies Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 45. Sanofi-Pasteur Sales Proportion of Human Rabies Vaccine by Product in 2023

Table 46. Sanofi-Pasteur Sales Proportion of Human Rabies Vaccine by Application in 2023

Table 47. Sanofi-Pasteur Sales Proportion of Human Rabies Vaccine by Geographic Area in 2023

Table 48. Sanofi-Pasteur Recent Development

Table 49. Chengda Bio Company Information

Table 50. Chengda Bio Description and Business Overview

Table 51. Chengda Bio Human Rabies Vaccine Product

Table 52. Chengda Bio Human Rabies Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 53. Chengda Bio Sales Proportion of Human Rabies Vaccine by Product in 2023

Table 54. Chengda Bio Sales Proportion of Human Rabies Vaccine by Application in 2023

Table 55. Chengda Bio Sales Proportion of Human Rabies Vaccine by Geographic Area in 2023

Table 56. Chengda Bio Recent Development

Table 57. KANGH Company Information

Table 58. KANGH Description and Business Overview

Table 59. KANGH Human Rabies Vaccine Product

Table 60. KANGH Human Rabies Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 61. KANGH Sales Proportion of Human Rabies Vaccine by Product in 2023

Table 62. KANGH Sales Proportion of Human Rabies Vaccine by Application in 2023

Table 63. KANGH Sales Proportion of Human Rabies Vaccine by Geographic Area in 2023

Table 64. KANGH Recent Development

Table 65. Prcmise Company Information

Table 66. Prcmise Description and Business Overview

Table 67. Prcmise Human Rabies Vaccine Product

Table 68. Prcmise Human Rabies Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 69. Prcmise Sales Proportion of Human Rabies Vaccine by Product in 2023

Table 70. Prcmise Sales Proportion of Human Rabies Vaccine by Application in 2023

Table 71. Prcmise Sales Proportion of Human Rabies Vaccine by Geographic Area in 2023

Table 72. Prcmise Recent Development

Table 73. Henan Grand Biopharma Company Information

Table 74. Henan Grand Biopharma Description and Business Overview

Table 75. Henan Grand Biopharma Human Rabies Vaccine Product

Table 76. Henan Grand Biopharma Human Rabies Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 77. Henan Grand Biopharma Sales Proportion of Human Rabies Vaccine by Product in 2023

Table 78. Henan Grand Biopharma Sales Proportion of Human Rabies Vaccine by Application in 2023

Table 79. Henan Grand Biopharma Sales Proportion of Human Rabies Vaccine by Geographic Area in 2023

Table 80. Henan Grand Biopharma Recent Development

Table 81. Zhuoyi Biological Company Information

Table 82. Zhuoyi Biological Description and Business Overview

Table 83. Zhuoyi Biological Human Rabies Vaccine Product

Table 84. Zhuoyi Biological Human Rabies Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 85. Zhuoyi Biological Sales Proportion of Human Rabies Vaccine by Product in 2023

Table 86. Zhuoyi Biological Sales Proportion of Human Rabies Vaccine by Application in 2023

Table 87. Zhuoyi Biological Sales Proportion of Human Rabies Vaccine by Geographic Area in 2023

Table 88. Zhuoyi Biological Recent Development

Table 89. ZhongKe Biopharm Company Information

Table 90. ZhongKe Biopharm Description and Business Overview

Table 91. ZhongKe Biopharm Human Rabies Vaccine Product

Table 92. ZhongKe Biopharm Human Rabies Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 93. ZhongKe Biopharm Sales Proportion of Human Rabies Vaccine by Product in 2023

Table 94. ZhongKe Biopharm Sales Proportion of Human Rabies Vaccine by Application in 2023

Table 95. ZhongKe Biopharm Sales Proportion of Human Rabies Vaccine by Geographic Area in 2023

Table 96. ZhongKe Biopharm Recent Development

Table 97. Ningbo Rongan Biological Company Information

Table 98. Ningbo Rongan Biological Description and Business Overview

Table 99. Ningbo Rongan Biological Human Rabies Vaccine Product

Table 100. Ningbo Rongan Biological Human Rabies Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 101. Ningbo Rongan Biological Sales Proportion of Human Rabies Vaccine by Product in 2023

Table 102. Ningbo Rongan Biological Sales Proportion of Human Rabies Vaccine by Application in 2023

Table 103. Ningbo Rongan Biological Sales Proportion of Human Rabies Vaccine by Geographic Area in 2023

Table 104. Ningbo Rongan Biological Recent Development

Table 105. Indian Immunologicals Company Information

Table 106. Indian Immunologicals Description and Business Overview

Table 107. Indian Immunologicals Human Rabies Vaccine Product

Table 108. Indian Immunologicals Human Rabies Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 109. Indian Immunologicals Sales Proportion of Human Rabies Vaccine by Product in 2023

Table 110. Indian Immunologicals Sales Proportion of Human Rabies Vaccine by Application in 2023

Table 111. Indian Immunologicals Sales Proportion of Human Rabies Vaccine by Geographic Area in 2023

Table 112. Indian Immunologicals Recent Development

Table 113. Global Human Rabies Vaccine Sales by Type (2019-2024) & (K Units)

Table 114. Global Human Rabies Vaccine Sales Forecast by Type (2025-2030) & (K Units)

Table 115. Global Human Rabies Vaccine Revenue by Type (2019-2024) & (US$ Million)

Table 116. Global Human Rabies Vaccine Revenue Forecast by Type (2025-2030) & (US$ Million)

Table 117. Global Human Rabies Vaccine Sales by Application (2019-2024) & (K Units)

Table 118. Global Human Rabies Vaccine Sales Forecast by Application (2025-2030) & (K Units)

Table 119. Global Human Rabies Vaccine Revenue by Application (2019-2024) & (US$ Million)

Table 120. Global Human Rabies Vaccine Revenue Forecast by Application (2025-2030) & (US$ Million)

Table 121. North America Human Rabies Vaccine Sales by Country (2019-2024) & (K Units)

Table 122. North America Human Rabies Vaccine Sales by Country (2025-2030) & (K Units)

Table 123. North America Human Rabies Vaccine Revenue by Country (2019-2024) & (US$ Million)

Table 124. North America Human Rabies Vaccine Revenue by Country (2025-2030) & (US$ Million)

Table 125. North America Human Rabies Vaccine Sales by Type (2019-2024) & (K Units)

Table 126. North America Human Rabies Vaccine Sales by Application (2019-2024) & (K Units)

Table 127. Asia-Pacific Human Rabies Vaccine Sales by Region (2019-2024) & (K Units)

Table 128. Asia-Pacific Human Rabies Vaccine Sales by Region (2025-2030) & (K Units)

Table 129. Asia-Pacific Human Rabies Vaccine Revenue by Region (2019-2030) & (US$ Million)

Table 130. Asia-Pacific Human Rabies Vaccine Revenue by Region (2025-2030) & (US$ Million)

Table 131. Asia-Pacific Human Rabies Vaccine Sales by Type (2019-2024) & (K Units)

Table 132. Asia-Pacific Human Rabies Vaccine Sales by Application (2019-2024) & (K Units)

Table 133. Europe Human Rabies Vaccine Sales by Country (2019-2024) & (K Units)

Table 134. Europe Human Rabies Vaccine Sales by Country (2025-2030) & (K Units)

Table 135. Europe Human Rabies Vaccine Revenue by Country (2019-2024) & (US$ Million)

Table 136. Europe Human Rabies Vaccine Revenue by Country (2025-2030) & (US$ Million)

Table 137. Europe Human Rabies Vaccine Sales by Type (2019-2024) & (K Units)

Table 138. Europe Human Rabies Vaccine Sales by Application (2019-2024) & (K Units)

Table 139. Latin America Human Rabies Vaccine Sales by Country (2019-2024) & (K Units)

Table 140. Latin America Human Rabies Vaccine Sales by Country (2025-2030) & (K Units)

Table 141. Latin America Human Rabies Vaccine Revenue by Country (2019-2024) & (US$ Million)

Table 142. Latin America Human Rabies Vaccine Revenue by Country (2025-2030) & (US$ Million)

Table 143. Latin America Human Rabies Vaccine Sales by Type (2019-2024) & (K Units)

Table 144. Latin America Human Rabies Vaccine Sales by Application (2019-2024) & (K Units)

Table 145. Middle East and Africa Human Rabies Vaccine Sales by Country (2019-2024) & (K Units)

Table 146. Middle East and Africa Human Rabies Vaccine Sales by Country (2025-2030) & (K Units)

Table 147. Middle East and Africa Human Rabies Vaccine Revenue by Country (2019-2024) & (US$ Million)

Table 148. Middle East and Africa Human Rabies Vaccine Revenue by Country (2025-2030) & (US$ Million)

Table 149. Middle East and Africa Human Rabies Vaccine Sales by Type (2019-2024) & (K Units)

Table 150. Middle East and Africa Human Rabies Vaccine Sales by Application (2019-2024) & (K Units)

Table 151. Human Rabies Vaccine Key Raw Materials, Industry Status and Trend

Table 152. Human Rabies Vaccine Key Raw Materials and Upstream Suppliers

Table 153. Human Rabies Vaccine Clients Status and Trend

Table 154. Human Rabies Vaccine Typical Clients

Table 155. Human Rabies Vaccine Distributors

Table 156. Human Rabies Vaccine Market Trends

Table 157. Human Rabies Vaccine Market Drivers

Table 158. Human Rabies Vaccine Market Challenges

Table 159. Human Rabies Vaccine Market Restraints

Table 160. Research Programs/Design for This Report

Table 161. Key Data Information from Secondary Sources

Table 162. Key Data Information from Primary Sources

List of Figures

Figure 1. Human Rabies Vaccine Product Picture

Figure 2. Global Human Rabies Vaccine Sales Market Share by Type in 2023 & 2030

Figure 3. Vero Cell Product Picture

Figure 4. BHK Product Picture

Figure 5. Chick Embryo Cell Product Picture

Figure 6. Human Diploid Cells Product Picture

Figure 7. Others Product Picture

Figure 8. Global Human Rabies Vaccine Sales Market Share by Application in 2023 & 2030

Figure 9. Pre-Exposure Vaccine Examples

Figure 10. Post-Exposure Vaccine Examples

Figure 11. Human Rabies Vaccine Report Years Considered

Figure 12. Global Human Rabies Vaccine Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 13. Global Human Rabies Vaccine Market Size 2019-2030 (US$ Million)

Figure 14. Global Human Rabies Vaccine Sales 2019-2030 (K Units)

Figure 15. Global Human Rabies Vaccine Sales Market Share Forecast by Region (2019-2030)

Figure 16. Global Human Rabies Vaccine Revenue Market Share by Region (2019-2030)

Figure 17. Global Human Rabies Vaccine Sales Share by Manufacturer in 2023

Figure 18. Human Rabies Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023

Figure 19. Global Human Rabies Vaccine Sales Market Share Forecast by Type (2019-2030)

Figure 20. Global Human Rabies Vaccine Revenue Market Share Forecast by Type (2019-2030)

Figure 21. Human Rabies Vaccine Average Selling Price (ASP) by Type (2019-2024) & (US$/Unit)

Figure 22. Global Human Rabies Vaccine Sales Market Share Forecast by Application (2019-2030)

Figure 23. Global Human Rabies Vaccine Revenue Market Share Forecast by Application (2019-2030)

Figure 24. Human Rabies Vaccine Average Selling Price (ASP) by Application (2019-2024) & (US$/Unit)

Figure 25. North America Human Rabies Vaccine Revenue 2019-2030 (US$ Million)

Figure 26. North America Human Rabies Vaccine Sales Market Share by Type (2019-2024)

Figure 27. North America Human Rabies Vaccine Sales Market Share by Application (2019-2024)

Figure 28. Asia-Pacific Human Rabies Vaccine Revenue 2019-2030 (US$ Million)

Figure 29. Asia-Pacific Human Rabies Vaccine Sales Market Share by Region (2019-2030)

Figure 30. Asia-Pacific Human Rabies Vaccine Revenue Market Share by Region (2019-2030)

Figure 31. Asia-Pacific Human Rabies Vaccine Sales Market Share by Type (2019-2024)

Figure 32. Asia-Pacific Human Rabies Vaccine Sales Market Share by Application (2019-2024)

Figure 33. Europe Human Rabies Vaccine Revenue Growth Rate 2019-2030 (US$ Million)

Figure 34. Europe Human Rabies Vaccine Sales Market Share by Country (2019-2030)

Figure 35. Europe Human Rabies Vaccine Revenue Market Share by Country (2019-2030)

Figure 36. Europe Human Rabies Vaccine Sales Market Share by Type (2019-2024)

Figure 37. Europe Human Rabies Vaccine Sales Market Share by Application (2019-2024)

Figure 38. Latin America Human Rabies Vaccine Revenue Growth Rate 2019-2030 (US$ Million)

Figure 39. Latin America Human Rabies Vaccine Sales Market Share by Country (2019-2030)

Figure 40. Latin America Human Rabies Vaccine Revenue Market Share by Country (2019-2024)

Figure 41. Latin America Human Rabies Vaccine Sales Market Share by Type (2019-2024)

Figure 42. Latin America Human Rabies Vaccine Sales Market Share by Application (2019-2024)

Figure 43. Middle East and Africa Human Rabies Vaccine Revenue Growth Rate 2019-2030 (US$ Million)

Figure 44. Middle East and Africa Human Rabies Vaccine Sales Market Share by Country (2019-2030)

Figure 45. Middle East and Africa Human Rabies Vaccine Revenue Market Share by Country (2019-2030)

Figure 46. Middle East and Africa Human Rabies Vaccine Sales Market Share by Type (2019-2024)

Figure 47. Middle East and Africa Human Rabies Vaccine Sales Market Share by Application (2019-2024)

Figure 48. Human Rabies Vaccine Supply Chain (Upstream and Downstream Market)

Figure 49. Global Production Market Share of Human Rabies Vaccine Raw Materials by Region in 2023

Figure 50. Human Rabies Vaccine Distribution Channels

Figure 51. Global Human Rabies Vaccine Percentage 2019-2030: Indirect Sales VS Direct Sales

Figure 52. Global Human Rabies Vaccine Percentage 2019-2030: Online Sales VS Offline Sales

Figure 53. Bottom-up and Top-down Approaches for This Report

Figure 54. Data Triangulation

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$5900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$8850

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$11800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions